Skip to content

Post-translation Modifications of the Synaptic Scaffold Controlling Age-Induced Memory Impairment (SyMetAge)

Age-dependent memory impairment (AMI) emerged as a widespread health threat during the last century and has since been affecting the quality of life for many senior citizens. AMI is characterised by symptoms of cognitive decline. Typically, it starts in mid-life and deepens with advancing age, suggesting that age itself is the greatest risk factor. But why do the elderly develop memory deficits? Investigations of brain regions with crucial roles in cognitive processing point towards age-related changes of synaptic structure and plasticity. However, causal relationships between these synaptic changes and AMI have yet to be established. The central hypothesis of the project »Post-translation Modifications of the Synaptic Scaffold Controlling Age-Induced Memory Impairment (SyMetAge)« is that an age-associated change in post-translational modifications (PTMs) provokes alterations in structural and functional plasticity of synapses. PTMs include, for example, phosphorylation, acetylation, methylation, ubiquitylation and neddylation. These modifications significantly affect the structure and dynamics of proteins and play a key role in numerous biological processes. »SyMetAge« aims to establish causal relations between lifetime-associated PTMs and memory impairment as well as deliver a conceptual frame for a mechanistic understanding of the phenomenon.

Molecular fingerprints of synapse ageing

The goal of this project is to establish a model of AMI that bridges the molecular status of identified memory-forming synapses with the behavioural display of memory. The project will lay the foundations for establishing AMI’s molecular fingerprints and identifying essential entry points for interventions in the cognitive decline.

»SyMetAge«’s primary objectives are:

1. Identifying dynamic phosphorylation events causally related to AMI.

2. Clarifying the role of specific phosphorylation events in modulating ageing-related functional and structural changes in presynaptic active zones.

3. Investigating how the mass relations in protein phosphorylation contribute to AMI by upshifting the size and release function of presynaptic active zones (RAMP-UP).

4. Identifying the molecular fingerprints of synapse ageing and age-induced memory impairment.

5. Determining the heterogeneity of acetylation, methylation, ubiquitylation, and neddylation at crucial lysine residues of memory relevant synaptic proteins.

To accomplish these, researchers at ISAS, are currently analysing peptide samples using proteomics approaches based on Liquid chromatography–mass spectrometry.

Share

Select publications

Cell Reports, Vol. 35, No. 2, 2021, P. 108941

Liang Y, Piao C, Beuschel CB, Toppe D, Kollipara L, Bogdanow B, Maglione M, Lützkendorf J, See JCK, Huang S, Conrad TOF, Kintscher U, Madeo F, Liu F,…

eIF5A hypusination, boosted by dietary spermidine, protects from premature brain aging and mitochondrial dysfunction

https://doi.org/10.1016/j.celrep.2021.108941

Further projects

Non-Radioactive Ionisation for Spectrometry & Spectroscopy (NORISC)

The objective of the »NORISC« project is to validate the Flexible microTube Plasma as an ionisation source.

Analysis of differential gene and protein expression for in-vitro detection of drug allergy

A research project at the Federal Institute for Drugs and Medical Devices (BfArM) - including ISAS - is dedicated to the improved detection of drug allergies.

Global Characterisation of Post-translational Modifications

Cells and tissue react very quickly to external stimuli. This project investigates the interactions between these dynamic changes and all kinds of diseases.

Multiomics: A systems biology approach for cardiovascular research

Current high-throughput methods for analysing proteins, nucleic acids, and metabolites are often limited to one molecule class only. This project aims to combine several omics techniques in a multimoics platform to investigate cardiovascular diseases.

Thromboinflammation in cardiovascular diseases

The European joint project »Thromboinflammation in cardiovascular diseases« (TICARDIO) combines the investigations into these two pathological processes for the first time under the heading “Thromboinflammation”.

Optimising Anaemia Treatment for Patients with Chronic Kidney Disease (NephrESA)

In order to treat anaemia more effectively, researchers in the »NephrESA« project are developing a computer model which can be used to determine the risks and prognoses of the medication for each individual affected.